Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.732 | 0.280 | 3 | 122284985 | missense variant | G/C | snv | 0.95 | 0.92 |
|
Endocrine System Diseases | 0.040 | 0.750 | 4 | 2001 | 2016 | ||||||
|
0.732 | 0.280 | 3 | 122284985 | missense variant | G/C | snv | 0.95 | 0.92 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.732 | 0.280 | 3 | 122284985 | missense variant | G/C | snv | 0.95 | 0.92 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.732 | 0.280 | 3 | 122284985 | missense variant | G/C | snv | 0.95 | 0.92 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
|
0.732 | 0.280 | 3 | 122284985 | missense variant | G/C | snv | 0.95 | 0.92 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.732 | 0.280 | 3 | 122284985 | missense variant | G/C | snv | 0.95 | 0.92 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.732 | 0.280 | 3 | 122284985 | missense variant | G/C | snv | 0.95 | 0.92 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.732 | 0.280 | 3 | 122284985 | missense variant | G/C | snv | 0.95 | 0.92 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.732 | 0.280 | 3 | 122284985 | missense variant | G/C | snv | 0.95 | 0.92 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.732 | 0.280 | 3 | 122284985 | missense variant | G/C | snv | 0.95 | 0.92 |
|
Digestive System Diseases | 0.010 | < 0.001 | 1 | 2007 | 2007 | ||||||
|
0.732 | 0.280 | 3 | 122284985 | missense variant | G/C | snv | 0.95 | 0.92 |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
|
0.732 | 0.280 | 3 | 122284985 | missense variant | G/C | snv | 0.95 | 0.92 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.732 | 0.280 | 3 | 122284985 | missense variant | G/C | snv | 0.95 | 0.92 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 |
|
Endocrine System Diseases | 0.080 | 0.875 | 8 | 2001 | 2016 | ||||||
|
0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.060 | 1.000 | 6 | 2006 | 2019 | ||||||
|
0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.060 | 1.000 | 6 | 2006 | 2019 | ||||||
|
0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2015 | 2017 | ||||||
|
0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2002 | 2009 | ||||||
|
0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2002 | 2009 | ||||||
|
0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 |